Stryker’s Moat Faces Intuitive Surgical Premium Valuation
Stryker and Intuitive Surgical reported divergent Q1 2026 results, underscoring two distinct medtech playbooks. Stryk...
On this medtech tag page, you'll find concise analyses and earnings insights for Medtronic, Nyxoah, Si-Bone, and more, helping you assess sector catalysts and make informed financial bets.
7 articlesStryker and Intuitive Surgical reported divergent Q1 2026 results, underscoring two distinct medtech playbooks. Stryk...
A struggling medtech name is sparking renewed optimism from analysts. This guide breaks down why a 65% upside is poss...
As investors parse Nano-X Imaging's Q4 2025 results, this guide breaks down the numbers, the business model, and what...
What really moved Si-Bone in Q1 2026? Our practical analysis breaks down revenue trends, margins, and the company’s a...
Discover how nyxoah (nyxh) 2025 earnings could shape an investor's view of MedTech plays. This forward-looking analys...
If you’re searching for a medical-device stock you can own for decades, Medtronic stands out. This article breaks dow...
In volatile markets, a company that sells essential medical devices can offer stability and income. This guide explai...